Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial

BACKGROUND: Lumbrokinase has been widely used for patients with acute ischemic stroke (AIS) in China; however, because rigorously designed studies are lacking, safety and efficacy of lumbrokinase in the treatment of acute ischemic stroke remains largely unknown. In this multicenter, randomized, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying, Liu, Yan, Zhang, Jingjing, Zhou, Kehua, Zhang, Xuecheng, Dai, Hengheng, Yang, Baolin, Shang, Hongcai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996506/
https://www.ncbi.nlm.nih.gov/pubmed/35410433
http://dx.doi.org/10.1186/s13063-022-06200-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996506/
https://www.ncbi.nlm.nih.gov/pubmed/35410433
http://dx.doi.org/10.1186/s13063-022-06200-4

Ejemplares similares